A cautionary note on design implications when the primary analysis is a stratified analysis of a binary endpoint

Biometrical Journal

Volumn 48, Issue 6, 2006, Pages 978-983

  Chuang Stein, Christy ^a  

^a PFIZER INC   (United States)

Author keywords

Cochran mantel haenszel procedure; Weighted average

Indexed keywords

COCHRAN-MANTEL-HAENSZEL PROCEDURE; DESIGN AND ANALYSIS; DESIGN IMPLICATIONS; PROPERTY; STRATIFIED ANALYSIS; WEIGHTED AVERAGES;

EID: 33846210940     PISSN: 03233847     EISSN: 15214036     Source Type: Journal    
DOI: 10.1002/bimj.200610291     Document Type: Article

References (9)

1. nd ed (Chapters 5, 7). New York: John Wiley & Sons.
2. Berger, V. W. (2004). Valid adjustment for binary covariates of randomized binary comparisons. Biometrical Journal 46, 589-594.
3. Berinard, G. R., Vincent, J. L., Laterre, P. F. et al. (2001). Efficacy and safety of recombinant human activated protein C for severe sepsis. New England Journal of Medicine 344, 699-709.
4. CPMP/EWP/2863/99 Points to Consider on Adjustment for Baseline Covariates (CPMP adopted May 2003). Available at http://www.emea.eu.int/pdfs/human/ewp/ 286399en.pdf.
5. Dmitrienko, A., Molenberghs, G., Chuang-Stein, C., and Offen, W. (2005). Analysis of Clinical Trials Using SAS: A Practical Guide (Chapter 1). Cary, NC: SAS Institute Inc.
6. Lachin, J. M. (2000). Biostatistics Methods: The Assessment of Relative Risks (Chapters 4, 7). New York: John Wiley & Sons.
7. Senn, S. (1997). Statistical Issues in Drug Development. Chichester, John Wiley and Sons.
8. nd ed. (Chapters 8, 9). Gary, NC: SAS Institute Inc.
9. Xigris package insert (2006). Available at http://pi.lilly.com/us/xigris. pdf.